Urokinase-type plasminogen activator receptor (uPAR) augments brain damage in a murine model of ischemic stroke

Neuroscience Letters

Volumn 432, Issue 1, 2008, Pages 46-49

  Nagai, Nobuo ^a   Okada, Kiyotaka ^a   Kawao, Naoyuki ^a   Ishida, Chikako ^a   Ueshima, Shigeru ^a,b   Collen, Desire ^c   Matsuo, Osamu ^a  

^a KINKI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b KINKI UNIVERSITY   (Japan)

^c UNIVERSITY OF LEUVEN   (Belgium)

Author keywords

Endothelial cells; Ischemic stroke; uPA; uPAR

Indexed keywords

UROKINASE; UROKINASE RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN CORTEX; BRAIN DAMAGE; CEREBROVASCULAR ACCIDENT; CONTROLLED STUDY; ENDOTHELIUM CELL; GENETIC DISORDER; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE CEREBRAL ARTERY OCCLUSION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; QUANTITATIVE ANALYSIS; UPREGULATION; WILD TYPE;

ANIMALS; BRAIN ISCHEMIA; DISEASE MODELS, ANIMAL; ENDOTHELIAL CELLS; INFARCTION, MIDDLE CEREBRAL ARTERY; MALE; MICE; MICE, INBRED BALB C; MICE, MUTANT STRAINS; RNA, MESSENGER; URINARY PLASMINOGEN ACTIVATOR;

EID: 38749101585     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neulet.2007.12.004     Document Type: Article

References (25)

1. Abumiya T., Lucero J., Heo J.H., Tagaya M., Koziol J.A., Copeland B.R., and del Zoppo G.J. Activated microvessels express vascular endothelial growth factor and integrin alpha(v)beta3 during focal cerebral ischemia. J. Cereb. Blood Flow Metab. 19 (1999) 1038-1050
2. Becker K., Kindrick D., Relton J., Harlan J., and Winn R. Antibody to the alpha4 integrin decreases infarct size in transient focal cerebral ischemia in rats. Stroke 32 (2001) 206-211
3. Beschorner R., Schluesener H.J., Nguyen T.D., Magdolen V., Luther T., Pedal I., Mattern R., Meyermann R., and Schwab J.M. Lesion-associated accumulation of uPAR/CD87-expressing infiltrating granulocytes, activated microglial cells/macrophages and upregulation by endothelial cells following TBI and FCI in humans. Neuropathol. Appl. Neurobiol. 26 (2000) 522-527
4. Blasi F., and Carmeliet P. uPAR: a versatile signalling orchestrator. Nat. Rev. Mol. Cell Biol. 3 (2002) 932-943
5. Campanella M., Sciorati C., Tarozzo G., and Beltramo M. Flow cytometric analysis of inflammatory cells in ischemic rat brain. Stroke 33 (2002) 586-592
6. Carmeliet P., Schoonjans L., Kieckens L., Ream B., Degen J., Bronson R., De Vos R., van den Oord J.J., Collen D., and Mulligan R.C. Physiological consequences of loss of plasminogen activator gene function in mice. Nature 368 (1994) 419-424
7. Chang D.I., Hosomi N., Lucero J., Heo J.H., Abumiya T., Mazar A.P., and del Zoppo G.J. Activation systems for latent matrix metalloproteinase-2 are upregulated immediately after focal cerebral ischemia. J. Cereb. Blood Flow Metab. 23 (2003) 1408-1419
8. Colman R.W., Pixley R.A., Najamunnisa S., Yan W., Wang J., Mazar A., and McCrae K.R. Binding of high molecular weight kininogen to human endothelial cells is mediated via a site within domains 2 and 3 of the urokinase receptor. J. Clin. Invest. 100 (1997) 1481-1487
9. Cubellis M.V., Andreasen P., Ragno P., Mayer M., Dano K., and Blasi F. Accessibility of receptor-bound urokinase to type-1 plasminogen activator inhibitor. Proc. Natl. Acad. Sci. U.S.A. 86 (1989) 4828-4832
10. Dewerchin M., Nuffelen A.V., Wallays G., Bouche A., Moons L., Carmeliet P., Mulligan R.C., and Collen D. Generation and characterization of urokinase receptor-deficient mice. J. Clin. Invest. 97 (1996) 870-878
11. Emerich D.F., Dean III R.L., and Bartus R.T. The role of leukocytes following cerebral ischemia: pathogenic variable or bystander reaction to emerging infarct?. Exp. Neurol. 173 (2002) 168-181
12. Huber J.D., Egleton R.D., and Davis T.P. Molecular physiology and pathophysiology of tight junctions in the blood-brain barrier. Trends Neurosci. 24 (2001) 719-725
13. Nagai N., De Mol M., Lijnen H.R., Carmeliet P., and Collen D. Role of plasminogen system components in focal cerebral ischemic infarction: a gene targeting and gene transfer study in mice. Circulation 99 (1999) 2440-2444
14. Nagai N., De Mol M., Van Hoef B., Verstreken M., and Collen D. Depletion of circulating alpha(2)-antiplasmin by intravenous plasmin or immunoneutralization reduces focal cerebral ischemic injury in the absence of arterial recanalization. Blood 97 (2001) 3086-3092
15. Nagai N., Demarsin E., Van Hoef B., Wouters S., Cingolani D., Laroche Y., and Collen D. Recombinant human microplasmin: production and potential therapeutic properties. J. Thromb. Haemost. 1 (2003) 307-313
16. Nagai N., Suzuki Y., Van Hoef B., Lijnen H.R., and Collen D. Effects of plasminogen activator inhibitor-1 on ischemic brain injury in permanent and thrombotic middle cerebral artery occlusion models in mice. J. Thromb. Haemost. 3 (2005) 1379-1384
17. Okada Y., Copeland B.R., Hamann G.F., Koziol J.A., Cheresh D.A., and del Zoppo G.J. Integrin alphavbeta3 is expressed in selected microvessels after focal cerebral ischemia. Am. J. Pathol. 149 (1996) 37-44
18. Powell E.M., Campbell D.B., Stanwood G.D., Davis C., Noebels J.L., and Levitt P. Genetic disruption of cortical interneuron development causes region- and GABA cell type-specific deficits, epilepsy, and behavioral dysfunction. J. Neurosci. 23 (2003) 622-631
19. Resnati M., Pallavicini I., Wang J.M., Oppenheim J., Serhan C.N., Romano M., and Blasi F. The fibrinolytic receptor for urokinase activates the G protein-coupled chemotactic receptor FPRL1/LXA4R. Proc. Natl. Acad. Sci. U.S.A. 99 (2002) 1359-1364
20. Shimamura N., Matchett G., Solaroglu I., Tsubokawa T., Ohkuma H., and Zhang J. Inhibition of integrin alphavbeta3 reduces blood-brain barrier breakdown in focal ischemia in rats. J. Neurosci. Res. 84 (2006) 1837-1847
21. Shimamura N., Matchett G., Yatsushige H., Calvert J.W., Ohkuma H., and Zhang J. Inhibition of integrin alphavbeta3 ameliorates focal cerebral ischemic damage in the rat middle cerebral artery occlusion model. Stroke 37 (2006) 1902-1909
22. Suzuki Y., Nagai N., Umemura K., Collen D., and Lijnen H.R. Stromelysin-1 (MMP-3) is critical for intracranial bleeding after t-PA treatment of stroke in mice. J. Thromb. Haemost. 5 (2007) 1732-1739
23. Wei Y., Lukashev M., Simon D.I., Bodary S.C., Rosenberg S., Doyle M.V., and Chapman H.A. Regulation of integrin function by the urokinase receptor. Science 273 (1996) 1551-1555
24. Wei Y., Waltz D.A., Rao N., Drummond R.J., Rosenberg S., and Chapman H.A. Identification of the urokinase receptor as an adhesion receptor for vitronectin. J. Biol. Chem. 269 (1994) 32380-32388
25. Zhang R.L., Chopp M., Chen H., and Garcia J.H. Temporal profile of ischemic tissue damage, neutrophil response, and vascular plugging following permanent and transient (2H) middle cerebral artery occlusion in the rat. J. Neurol. Sci. 125 (1994) 3-10